Entries tagged "pharma mergers"

More antitrust scrutiny for pharmas

At The Deal LLC's Healthcare Dealmaking Symposium, a Tuesday morning panel discussed the possibility of growing antitrust scrutiny by the Obama administration for healthcare deals.

OrbiMed's Sam Isaly on healthcare M&A

Sam Isaly, the founder and managing partner at private equity firm OrbiMed Advisor, was the subject of the Tuesday morning keynote interview at The Deal LLC's Healthcare Dealmaking Symposium.

Sullivan & Cromwell's Pagnani on biotech M&A

At The Deal LLC's Healthcare Dealmaking Symposium, attorney Keith Pagnani commented on how the dealmaking landscape for biotechs is changing.

Dealmaker sees healthcare M&A slowdown

Richard H. Stowe, general partner at Health Enterprise Partners, said the recession is taking its toll on healthcare and pharma mergers despite a few recent megadeals.

Enfamil IPO to make Bristol-Myers easier to swallow?

As rival pharmaceutical companies begin to pair up, Bristol-Myers Squibb prepares to unload its children's nutrition unit Mead Johnson.

Here comes pharma's 'me-too' mergers

The pharmaceutical industry is notorious for creating copycat drugs. Now Pfizer's $68 billion bid for Wyeth could prompt Merck, Sanofi-Aventis and other peers to launch 'me-too' mergers.

Top tags

• M&A (1067)
• bankruptcy (543)
• private equity (519)
• politics (396)
• credit crisis (361)
• banks (353)
• Bank of America (349)
• banking (333)
• Citigroup (318)
• layoffs (312)